Cyclophosphamide followed by Intravenous Targeted Busulfan for Allogeneic Hematopoietic Cell Transplantation: Pharmacokinetics and Clinical Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cyclophosphamide followed by Intravenous Targeted Busulfan for Allogeneic Hematopoietic Cell Transplantation: Pharmacokinetics and Clinical Outcomes

Published:2013-07 Issue:7 Volume:19 Page:1033-1039
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Rezvani Andrew R.,McCune Jeannine S.,Storer Barry E.,Batchelder Ami,Kida Aiko,Deeg H. Joachim,McDonald George B.

Funder

CA09515

CA18029

CA15704

CA162059

CA76930

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation;Slattery;Blood,1997

2. Graft rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics;Slattery;Bone Marrow Transplant,1995

3. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age;Alyea;Blood,2005

4. Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS;Deeg;Blood,2012

5. Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation;DeLeve;Hepatology,1996

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2024-09-13

2. Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics;Advances in Pharmacological and Pharmaceutical Sciences;2024-01

3. Preparative Regimens Used in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapies;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. How I treat transplant-eligible patients with myelofibrosis;Blood;2023-11-16

5. Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose;Human Pathology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3